LRIG1 | Lig-1, Blocking peptide
-
Catalog number
AS06 148P
-
Price
Please ask
-
Size
100 µg
-
-
Available ordering format
Lyophilized
-
Immunogen
to be determined
-
Raised in
N/A
-
Clonality
N/A
-
Clone
N/A
-
Purification
Affinity purified
-
How to reconstitute
For reconstitution please add sterile water
-
Storage condition
store at -20°C; make aliquots to avoid repeated freeze-thaw cycles. Please, remember to spin tubes briefly prior to opening them to avoid any losses that might occur from lyophilized material adhering to the cap or sides of the tubes.
-
Verified applications
Neutralization assay
-
Connected products
AS06 148 | LRIG1 | Lig-1
-
Recommended dilutions for use
see datasheet
-
Molecular weight expected аpparent
1644.66 Da
-
Verified reactivity
to be determined
-
Possible reactivity
to be determined
-
No reactivity
to be determined
-
Supplementary information
Estimation of the ratio between antibodies and a peptide : In neutralisation assay use 8.77 µg of LRIG1 peptide for 10 ml of reaction volume. In case of any questions please contact [email protected]
-
References
Refer to PubMed
-
Scientific context
This blocking peptide can be used as a control to neutralize LRIG1 | Lig-1 before immunolocalization or western blot. Furter details are provided below.LRIG1 protein Q96JA1 is coded by a gene on a chromosome band 3p14.3, this region is known to be deleted in various human cancers. LRIG1 is considered to be a a tumour suppressor gene in humans. LRIG1 is an integral cell-surface membrane protein that is expressed by specific cells in various human tissues and that its 143-kDa form might be cleaved into 111-kDa and 32-kDa fragments. The LRIG1 protein may inhibit the growth of tumors of glial cells and the down-regulation of the LRIG1 gene may be involved in the development and progression of the tumor.
-
Notes
None
-
Protein number
Refer to NCBI
-
TAIR number
Refer to NCBI
-
-
Test
You can block the antibody by the specific target amino acid sequence of peptide.
-
Properties
blocking peptide
-
Description
Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
-
Gene target
-
Gene symbol
LRIG1
-
Short name
LRIG1 | Lig-1, Blocking peptide
-
Technique
blocking peptide, Blocking, peptide, blocking peptides, agisera made this blocking amino acid sequence or peptide to block the gene target in a volume of 1. For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear. This is called a negative control by blocking the WB antibody. peptides
-
Alternative name
leucine-rich repeats and immunoglobulin-like domains 1 | Lig-1, inhibiting short protein sequence
-
Alternative technique
control, peptides
-
Alternative to gene target
leucine-rich repeats and immunoglobulin-like domains 1, LIG-1 and LIG1, LRIG1 and IDBG-43579 and ENSG00000144749 and 26018, protein binding, Plasma membranes, Lrig1 and IDBG-171701 and ENSMUSG00000030029 and 16206, LRIG1 and IDBG-645083 and ENSBTAG00000010360 and 505750
-
Gene info
Similar products
